ING Investment Management »

iShares NASDAQ Biotechnology Index shares owned by ING Investment Management

Quarter-by-quarter ownership of iShares NASDAQ Biotechnology Index (IBB) shares owned by ING Investment Management from 13F filings

Historical chart of ING Investment Management investment in iShares NASDAQ Biotechnology Index

Tip: Access up to 7 years of quarterly data

All positions including iShares NASDAQ Biotechnology Index held by ING Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in iShares NASDAQ Biotechnology Index by ING Investment Management

Quarter filed Position value Share count Share price at filing
2013-03-31 $960k 6.0k 160.00

More positions owned by ING Investment Management

Pfizer (PFE)
Microsoft Corporation (MSFT)
JPMorgan Chase & Co. (JPM)
Google
General Electric Company
Apple (AAPL)
Procter & Gamble Company (PG)
At&t (T)
Wells Fargo & Company (WFC)
Merck & Co (MRK)
Occidental Petroleum Corporation (OXY)
Spdr S&p 500 Etf (SPY)
Citigroup (C)
Pepsi (PEP)
Johnson & Johnson (JNJ)

View all positions for ING Investment Management

Top funds holding iShares NASDAQ Biotechnology Index

Bank of America Corporation
Elliott Investment Management
Citigroup
Goldman Sachs Group
Bnp Paribas Arbitrage, Snc
Jpmorgan Chase & Co
UBS Group
Citadel Advisors
Royal Bank of Canada
Susquehanna International
Barclays
Commerce Bank N A
Wells Fargo & Company
LPL Financial
Main Management ETF Advisors

View all funds holding iShares NASDAQ Biotechnology Index